09415
Sodium 4-aminosalicylate dihydrate
≥97.0% (T)
Synonym(s):
4-Amino-2-hydroxybenzoic acid sodium salt, 4-Amino-salicylic acid sodium salt
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C7H6NNaO3 · 2H2O
CAS Number:
Molecular Weight:
211.15
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
205-091-2
MDL number:
Assay:
≥97.0% (T)
Form:
powder
Quality Segment
assay
≥97.0% (T)
form
powder
reaction suitability
reaction type: solution phase peptide synthesis
technique(s)
ligand binding assay: suitable
color
white to faintly beige
application(s)
peptide synthesis
SMILES string
O.O.[Na+].Nc1ccc(c(O)c1)C([O-])=O
InChI
1S/C7H7NO3.Na.2H2O/c8-4-1-2-5(7(10)11)6(9)3-4;;;/h1-3,9H,8H2,(H,10,11);;2*1H2/q;+1;;/p-1
InChI key
GMUQJDAYXZXBOT-UHFFFAOYSA-M
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cezary Chojnacki et al.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 31(182), 92-96 (2011-09-23)
In order to maintain ulcerative colitis (UC) in remission, chronic use of aminosalicylates is recommended. All patients have a fear of the recurrence of symptoms, which makes their mental state and quality of life worse. Because of this a number
Sumit Chakraborty et al.
Science (New York, N.Y.), 339(6115), 88-91 (2012-11-03)
Folate biosynthesis is an established anti-infective target, and the antifolate para-aminosalicylic acid (PAS) was one of the first anti-infectives introduced into clinical practice on the basis of target-based drug discovery. Fifty years later, PAS continues to be used to treat
Shuichi Yano et al.
BMJ case reports, 2012, doi:10-doi:10 (2012-05-19)
Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 278777-10G | 04061837836961 |
| 09415-50G | 04061838344724 |